Am J Transplant, Volume 20, Suppl 3 Archives - Page 11 of 223 - ATC Abstracts

2020 American Transplant Congress
Solid Organ Transplantation Using Hepatitis C Virus Positive Donor Organs for Hepatitis C Virus Negative Recipients
T. Schiff, R. Bodin, I. Lee, K. Okumura, D. C. Wolf, A. Dhand, A. L. Gass, D. Spielvogel, G. Veillette, S. Nishida, D. Glicklich, K. Wolfe, T. Diflo, H. Sogawa
New York Medical College/ Westchester Medical Center, Valhalla, NY
*Purpose: To determine the effects of transplanting an HCV-positive solid organ to an uninfected patient who is on the transplant waiting list and might otherwise…
2020 American Transplant Congress
Waitlisted Patients’ Preferences for Accepting and Consenting to Transplantation with Experimentally Manipulated Organs
E. J. Gordon¹, P. Abt², C. Phillips², F. Bermudez², B. Knopf¹, J. Lee¹, R. Veatch³, R. Knight⁴, P. T. Conway⁴, J. Goldstein⁵, S. Dunn⁶, P. Reese²
¹Northwestern University, Chicago, IL, ²University of Pennsylvania, Philadelphia, PA, ³Georgetown University, Washington, DC, ⁴American Association of Kidney Patients, Tampa, FL, ⁵Lung Transplant Foundation, Raleigh, NC, ⁶Donor Alliance, Denver, CO
*Purpose: Organ donor intervention research (“intervention research”) aims to increase organ quality and quantity for transplantation by protecting against organ injury and enhancing functionality. Given…
2020 American Transplant Congress
RN Specialty Practice to Optimize Enteric Hyperoxaluria Management – A Qi Project
B. M. Amberg, M. R. D'Costa, J. L. Wells-Pittman, A. R. Frodermann, E. M. Dahlen, G. M. Davidson, T. L. Mueller, C. A. Nash, T. I. Schnell, H. Amer, J. C. Lieske
Mayo Clinic, Rochester, MN
*Purpose: Optimal management of enteric hyperoxaluria (EH) requires institution of a strict low-fat, low oxalate diet and use of oral calcium supplements as oxalate binders.…
2020 American Transplant Congress
Organ Donation in Perú: Why are We Failing? Conclusions from the Last 5 Years
M. Moreno Gonzales, J. Duran, O. Ponce, G. Navarro, M. Benavides
Instituto Nacional de Salud del Niño de San Borja, Lima, Peru
*Purpose: The scarcity of deceased donor organs is still an unmet need in transplantation worldwide. This dilemma is significantly important in several Latin American nations.…
2020 American Transplant Congress
The Heart of the Matter: The Impact of the 2018 Heart Allocation Policy at a Single Organ Procurement Organization
A. J. Boyer, J. B. Nave, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: In 2018, allocation policy changed with the goal of lowering waitlist mortality by increasing access to donor hearts. We sought to describe the impact…
2020 American Transplant Congress
Effect of Intravenous Ferric Gluconate on Post Heart Transplant Outcomes in Patients Bridged with Left Ventricular Assist Devices
N. Krepostman, D. Kim, D. Masic, S. Kuhrau, J. Negrelli, M. Liebo, E. Raichlin, A. Heroux, H. Basha
Internal Medicine, Loyola University Medical Center, Maywood, IL
*Purpose: Our study examined the effect of intravenous (IV) ferric gluconate compared to oral iron repletion in reducing 30-day hospital readmissions and all-cause mortality in…
2020 American Transplant Congress
Case Series of Belatacept for Calcineurin Inhibitor Sparing after Lung Transplantation
H. Patel, C. R. Ensor, R. D. Davis, L. Bogar, D. Colella, M. Kildea, J. Kim, A. Satterthwaite, D. Ventura, C. Gries
AdventHealth, Orlando, FL
*Purpose: Belatacept is a recombinant soluble fusion protein which selectively blocks T-cell co-stimulation. It received initial FDA approval for prophylaxis of organ rejection in Epstein-Barr…
2020 American Transplant Congress
Incidence and Influencing Factors of Venous Thromboembolism after Lung Transplantation
L. Fan¹, J. Chen², B. Wu¹, Z. Zhai³
¹Pulmonary and Critical Care Medicine, Wuxi People’s Hospital, Wuxi, China, ²Thoracic Surgery, Wuxi People’s Hospital, Wuxi, China, ³Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China
*Purpose: To analyze the incidence and influencing factors of venous thromboembolism (VTE) after lung transplantation.*Methods: This study retrospectively analyzed the clinical data of 375 lung…
2020 American Transplant Congress
Beta Cell Replacement Therapy in Nonuremic Patients with Brittle T1DM Allows for Durable Long Term Insulin Independence Halting Progression of Secondary Diabetic Complications
P. J. Bachul¹, D. J. Grybowski¹, R. Anteby², L. Basto¹, L. Perea¹, K. Golab¹, L. Wang¹, M. Tibudan¹, A. Perez-Gutierrez¹, M. Komorniczak³, A. Lucander¹, P. Borek¹, M. Dimitrov¹, J. Fung¹, P. Witkowski¹
¹Surgery, University of Chicago, Chicago, IL, ²Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, ³Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
*Purpose: Beta cell replacement therapy in form of pancreas or islet transplantation is the only effective treatment for patients suffering from hypoglycemic unawareness despite intensive…
2020 American Transplant Congress
Impact of Kidney Transplant Type and Previous Transplant on Baseline Donor-Derived Cell Free DNA
K. K. Sureshkumar, B. Chopra
Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, PA
*Purpose: Donor derived-cell free DNA (dd-cfDNA) is a biomarker useful in predicting acute rejection in renal allografts. The technology uses next generation sequencing and does…